focus -WSS

focus

author：leisure time 2025-09-29 21:21:02 - browse：99324

John Thune raises one hand while speaking to the press at the Capitol 2024 — politics coverage from STAT — Sen. John Thune is one of a group of lawmakers that is working on 340B reform legislation. BRENDAN SMIALOWSKI/AFP via Getty Images

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT.

The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years. The draft legislation makes a number of changes to address some of the most controversial points, including its rules over so-called “contract pharmacies” and which subsidiaries can qualify for discounts.

The draft would also require more oversight, and it would give the Health Resources and Services Administration more money to do it with a new user fee program. Providers would pay HRSA up to 0.1% of the savings it receives from the program.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Average age of first period drops to 11.9 years, study shows

WSS

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Cue Health's Covid

AI used to predict Covid

Average age of first period drops to 11.9 years, study shows

Health care needs a new profession: neuroimaging counseling

Key Senate committee drafts bipartisan bill to stem drug shortages

knowledge

focus

leisure time

Psychedelics group wrestles with new pharma identity

Cue Health's Covid

Hepatitis C has a cure — but many Americans still lack access to it

Dark money group runs ads on China biotech bill

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Dogs on Prozac: What pet anti

In Memoriam: Notable people who died in 2023

Melinda French Gates resigns from Gates Foundation

Heart attack and stroke risk calculators need revising

MassMutual is introducing free genetic testing for members

knowledge

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Diversity in clinical trials starts with building trust, experts say

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Getting Alzheimer's drug Leqembi to patients can be a challenge

Exact Sciences stock tumbles despite strong cancer detection sales

Wikipedia

hotspot

entertainment

focus